Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,935,107
+$8,515,219 QoQ
Shares Held
481,997
+62.3% QoQ
Ownership
0.614%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 252 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2022CallValue
$1,078,400
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CLDX ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CLDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,935,107 | 481,997 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,419,888 | 296,970 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,866,706 | 326,462 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $10,773,483 | 416,447 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,119,355 | 841,246 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,648,555 | 1,468,240 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,850,170 | 389,797 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,662,631 | 166,597 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,943,657 | 160,596 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,758,925 | 256,348 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,269,927 | 158,092 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $583,286 | 21,195 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $26,363 | 777 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,190,282 | 60,875 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,314,658 | 119,243 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,038,045 | 36,928 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,078,400 | 40,000 | Call | Defined | 2022-08-10 | |
| 2022-06-30 | $2,002,534 | 74,278 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,476,131 | 160,779 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,045,996 | 130,590 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,555,129 | 47,326 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $679,266 | 20,313 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,129,889 | 54,849 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $48,319 | 2,758 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $23,282 | 1,570 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,670 | 590 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,488 | 897 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||